DZ Bank’s Regenxbio RGNX Stock Holding History

DZ Bank’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-12,978	Closed	-$387K	–	1044
2018 Q1	$387K	Buy	+12,978	New	+$378K	﹤0.01%	831

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DZ Bank's RGNX Position: Q2 2018 in Review

DZ Bank sold out of Regenxbio (RGNX) in Q2 2018, closing a stake of 12,978 shares — an estimated $387K sold.

DZ Bank first reported a position in RGNX in Q1 2018 and held it in 1 quarter. The position peaked at $387K in Q1 2018. 177 funds tracked by Wall St. Rank hold RGNX as of Q2 2018.

DZ Bank reported no remaining Regenxbio position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 12,978 Regenxbio shares in Q2 2018, an estimated $387K.
DZ Bank first reported a position in Regenxbio in Q1 2018 and held it in 1 quarter.
DZ Bank's Regenxbio position peaked at $387K in Q1 2018.
177 funds tracked by Wall St. Rank held Regenxbio as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.